{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T15:44:06Z","timestamp":1789055046066,"version":"build-2803163510"},"reference-count":138,"publisher":"Bentham Science Publishers Ltd.","issue":"11","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CMC"],"published-print":{"date-parts":[[2024,4]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract:<\/jats:title>\n                    <jats:p>In recent years, substantial advances have been made in cancer treatment modalities.\nYet, within the last three decades, neither cancer incidence nor the cancer-induced\nmortality rate has changed. Available anti-cancer chemotherapeutics possess remarkably\nrestricted effectiveness and often have severe adverse effects. Hence, the identification\nof novel pharmaceutical agents that do not exhibit these major disadvantages is\nimperative. Melatonin, an important endogenous molecule synthesized and secreted by\nthe pineal gland, is a promising chemical agent that has been comprehensively assessed\nover the last decades for its anti-inflammatory and anti-cancer properties. Melatonin is reportedly\na significant inhibitor of cancer initiation, progression, and metastasis. The anti--\ncancer potential of melatonin is principally mediated by reversing the up-regulated\namounts of different transcription factors, growth factors, inflammatory cytokines, protein\nkinases, and other oncogenic agents. Also, melatonin often has signifcant inhibitory\neffects on cancer cell proliferation through either promoting apoptosis or inducing cell cycle\narrest. The current review provides an insight into melatonin-induced effects against\nvarious human cancers with a particular focus on the regulation of Wnt\/\u03b2-catenin signaling\npathway.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/0929867330666230409141957","type":"journal-article","created":{"date-parts":[[2023,12,26]],"date-time":"2023-12-26T01:42:35Z","timestamp":1703554955000},"page":"1315-1331","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Melatonin as a Promising Agent for Cancer Treatment: Insights into\nits Effects on the Wnt\/beta-catenin Signaling Pathway"],"prefix":"10.2174","volume":"31","author":[{"given":"Amirhossein","family":"Davoodvandi","sequence":"first","affiliation":[{"name":"Student Research Committee, Kashan University of Medical Sciences, Kashan, Iran"},{"name":"Cancer Immunology Project (CIP), Universal Scientific Education and Research Network (USERN), Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Asemi","sequence":"additional","affiliation":[{"name":"Department\nof Internal Medicine, School of Medicine, Cancer Prevention Research Center, Seyyed Al-Shohada Hospital,\nIsfahan University of Medical Sciences, Isfahan, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehran","family":"Sharifi","sequence":"additional","affiliation":[{"name":"Department\nof Internal Medicine, School of Medicine, Cancer Prevention Research Center, Seyyed Al-Shohada Hospital,\nIsfahan University of Medical Sciences, Isfahan, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Russel J.","family":"Reiter","sequence":"additional","affiliation":[{"name":"Department of Cell Systems and Anatomy, UT\nHealth Long School of Medicine, San Antonio, TX, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Amirhassan","family":"Matini","sequence":"additional","affiliation":[{"name":"Department of Pathology, School of Medicine,\nKashan University of Medical Sciences, Kashan, I.R. Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyyed Mehdi","family":"Mirhashemi","sequence":"additional","affiliation":[{"name":"Metabolic Diseases Research Center, Research\nInstitute for Prevention of Non-Communicable Diseases, Qazvin University of Medical Sciences, Qazvin,\nIran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zatollah","family":"Asemi","sequence":"additional","affiliation":[{"name":"Research Center for Biochemistry and Nutrition in Metabolic Diseases, Institute for Basic Sciences,\nKashan University of Medical Sciences, Kashan, I.R. Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21708","volume":"72","author":"Siegel R.L.","year":"2022","unstructured":"Siegel R.L.; Miller K.D.; Fuchs H.E.; Jemal A.; Cancer statistics, 2022. CA Cancer J Clin  2022,72(1),7-33","journal-title":"CA Cancer J Clin"},{"key":"ref=2","first-page":"229","author":"Gupta A.P.","year":"2013","unstructured":"Gupta A.P.; Pandotra P.; Sharma R.; Kushwaha M.; Gupta S.; Marine resource: A promising future for anticancer drugs. Studies in natural products chemistry.  Elsevier Inc  2013,229-325","journal-title":"Elsevier Inc"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/s41392-020-0134-x","volume":"5","author":"Fares J.","year":"2020","unstructured":"Fares J.; Fares M.Y.; Khachfe H.H.; Salhab H.A.; Fares Y.; Molecular principles of metastasis: A hallmark of cancer revisited. Signal Transduct Target Ther  2020,5(1),28","journal-title":"Signal Transduct Target Ther"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1038\/nrc3397","volume":"12","author":"Umar A.","year":"2012","unstructured":"Umar A.; Dunn B.K.; Greenwald P.; Future directions in cancer prevention. Nat Rev Cancer  2012,12(12),835-848","journal-title":"Nat Rev Cancer"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.ejmech.2018.06.057","volume":"156","author":"Piska K.","year":"2018","unstructured":"Piska K.; Gunia-Krzy\u017cak A.; Koczurkiewicz P.; W\u00f3jcik-Pszczo\u0142a K.; P\u0119kala E.; Piperlongumine (piplartine) as a lead compound for anticancer agents \u2013 Synthesis and properties of analogues: A mini-review. Eur J Med Chem  2018,156,13-20","journal-title":"Eur J Med Chem"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"483","DOI":"10.3390\/cancers10120483","volume":"10","author":"Leary M.","year":"2018","unstructured":"Leary M.; Heerboth S.; Lapinska K.; Sarkar S.; Sensitization of drug resistant cancer cells: A matter of combination therapy. Cancers  2018,10(12),483","journal-title":"Cancers"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"7069","DOI":"10.1002\/anie.201916400","volume":"59","author":"Karges J.","year":"2020","unstructured":"Karges J.; Yempala T.; Tharaud M.; Gibson D.; Gasser G.; A multi-action and multi-target Ru  \u2013Pt  conjugate combining cancer-activated chemotherapy and photodynamic therapy to overcome drug resistant cancers. Angew Chem Int Ed  2020,59(18),7069-7075","journal-title":"Angew Chem Int Ed"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s10456-019-09689-7","volume":"23","author":"Ma Q.","year":"2020","unstructured":"Ma Q.; Reiter R.J.; Chen Y.; Role of melatonin in controlling angiogenesis under physiological and pathological conditions. Angiogenesis  2020,23(2),91-104","journal-title":"Angiogenesis"},{"key":"ref=9","first-page":"2747","volume":"32","author":"Cutando A.","year":"2012","unstructured":"Cutando A.; L\u00f3pez-Valverde A.; Arias-Santiago S.; DE Vicente J.; DE Diego R.G.; Role of melatonin in cancer treatment. Anticancer Res  2012,32(7),2747-2753","journal-title":"Anticancer Res"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"3603","DOI":"10.1096\/fj.10-154450","volume":"24","author":"Luchetti F.","year":"2010","unstructured":"Luchetti F.; Canonico B.; Betti M.; Arcangeletti M.; Pilolli F.; Piroddi M.; Canesi L.; Papa S.; Galli F.; Melatonin signaling and cell protection function. FASEB J  2010,24(10),3603-3624","journal-title":"FASEB J"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"12143","DOI":"10.3390\/ijms222212143","volume":"22","author":"Markus R.P.","year":"2021","unstructured":"Markus R.P.; Sousa K.S.; da Silveira Cruz-Machado S.; Fernandes P.A.; Ferreira Z.S.; Possible role of pineal and extra-pineal melatonin in surveillance, immunity, and first- line defense. Int J Mol Sci  2021,22(22),12143","journal-title":"Int J Mol Sci"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1517\/13543784.2012.681045","volume":"21","author":"Sanchez-Barcelo E.J.","year":"2012","unstructured":"Sanchez-Barcelo E.J.; Mediavilla M.D.; Alonso-Gonzalez C.; Reiter R.J.; Melatonin uses in oncology: Breast cancer prevention and reduction of the side effects of chemotherapy and radiation. Expert Opin Investig Drugs  2012,21(6),819-831","journal-title":"Expert Opin Investig Drugs"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s11658-022-00375-z","volume":"27","author":"Davoodvandi A.","year":"2022","unstructured":"Davoodvandi A.; Nikfar B.; Reiter R.J.; Asemi Z.; Melatonin and cancer suppression: Insights into its effects on DNA methylation. Cell Mol Biol Lett  2022,27(1),73","journal-title":"Cell Mol Biol Lett"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"110659","DOI":"10.1016\/j.nut.2019.110659","volume":"72","author":"Talib W.H.","year":"2020","unstructured":"Talib W.H.; A ketogenic diet combined with melatonin overcomes cisplatin and vincristine drug resistance in breast carcinoma syngraft. Nutrition  2020,72,110659","journal-title":"Nutrition"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"324","DOI":"10.4103\/0973-1482.235349","volume":"14","author":"Talib W.H.","year":"2018","unstructured":"Talib W.H.; Odeh L.H.; Basheti I.; Synergistic effect of thymoquinone and melatonin against breast cancer implanted in mice. J Cancer Res Ther  2018,14(S9),324","journal-title":"J Cancer Res Ther"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.neuchi.2015.03.002","volume":"61","author":"Claustrat B.","year":"2015","unstructured":"Claustrat B.; Leston J.; Melatonin: Physiological effects in humans. Neurochirurgie  2015,61(2-3),77-84","journal-title":"Neurochirurgie"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"e12672","DOI":"10.1111\/jpi.12672","volume":"69","author":"Boutin J.A.","year":"2020","unstructured":"Boutin J.A.; Witt-Enderby P.A.; Sotriffer C.; Zlotos D.P.; Melatonin receptor ligands: A pharmaco-chemical perspective. J Pineal Res  2020,69(3),e12672","journal-title":"J Pineal Res"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"681","DOI":"10.3390\/cells8070681","volume":"8","author":"Salehi B.","year":"2019","unstructured":"Salehi B.; Sharopov F.; Fokou P.; Kobylinska A.; Jonge L.; Tadio K.; Sharifi-Rad J.; Posmyk M.; Martorell M.; Martins N.; Iriti M.; Melatonin in medicinal and food plants: occurrence, bioavailability, and health potential for humans. Cells  2019,8(7),681","journal-title":"Cells"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"472","DOI":"10.20945\/2359-3997000000066","volume":"62","author":"Amaral F.G.","year":"2018","unstructured":"Amaral F.G.; Cipolla-Neto J.; A brief review about melatonin, a pineal hormone. Arch Endocrinol Metab  2018,62(4),472-479","journal-title":"Arch Endocrinol Metab"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.tem.2007.10.007","volume":"19","author":"Slominski A.","year":"2008","unstructured":"Slominski A.; Tobin D.J.; Zmijewski M.A.; Wortsman J.; Paus R.; Melatonin in the skin: Synthesis, metabolism and functions. Trends Endocrinol Metab  2008,19(1),17-24","journal-title":"Trends Endocrinol Metab"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1210\/edrv-12-2-151","volume":"12","author":"Reiter R.J.","year":"1991","unstructured":"Reiter R.J.; Pineal melatonin: Cell biology of its synthesis and of its physiological interactions. Endocr Rev  1991,12(2),151-180","journal-title":"Endocr Rev"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"12142","DOI":"10.1002\/jcp.28129","volume":"234","author":"Pourhanifeh M.H.","year":"2019","unstructured":"Pourhanifeh M.H.; Mahdavinia M.; Reiter R.J.; Asemi Z.; Potential use of melatonin in skin cancer treatment: A review of current biological evidence. J Cell Physiol  2019,234(8),12142-12148","journal-title":"J Cell Physiol"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"2702","DOI":"10.1111\/bph.13536","volume":"173","author":"Jockers R.","year":"2016","unstructured":"Jockers R.; Delagrange P.; Dubocovich M.L.; Markus R.P.; Renault N.; Tosini G.; Cecon E.; Zlotos D.P.; Update on melatonin receptors: IUPHAR Review 20. Br J Pharmacol  2016,173(18),2702-2725","journal-title":"Br J Pharmacol"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1146\/annurev-pharmtox-010814-124742","volume":"56","author":"Liu J.","year":"2016","unstructured":"Liu J.; Clough S.J.; Hutchinson A.J.; Adamah-Biassi E.B.; Popovska-Gorevski M.; Dubocovich M.L.; MT1 and MT2 melatonin receptors: A therapeutic perspective. Annu Rev Pharmacol Toxicol  2016,56(1),361-383","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"2921","DOI":"10.1007\/s00429-017-1439-6","volume":"222","author":"Ng K.Y.","year":"2017","unstructured":"Ng K.Y.; Leong M.K.; Liang H.; Paxinos G.; Melatonin receptors: Distribution in mammalian brain and their respective putative functions. Brain Struct Funct  2017,222(7),2921-2939","journal-title":"Brain Struct Funct"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1111\/febs.15128","volume":"287","author":"Stauch B.","year":"2020","unstructured":"Stauch B.; Johansson L.C.; Cherezov V.; Structural insights into melatonin receptors. FEBS J  2020,287(8),1496-1510","journal-title":"FEBS J"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"118934","DOI":"10.1016\/j.lfs.2020.118934","volume":"267","author":"Moloudizargari M.","year":"2021","unstructured":"Moloudizargari M.; Moradkhani F.; Hekmatirad S.; Fallah M.; Asghari M.H.; Reiter R.J.; Therapeutic targets of cancer drugs: Modulation by melatonin. Life Sci  2021,267,118934","journal-title":"Life Sci"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.3390\/ijms19082205","volume":"19","author":"Bondy S.C.","year":"2018","unstructured":"Bondy S.C.; Campbell A.; Mechanisms underlying tumor suppressive properties of melatonin. Int J Mol Sci  2018,19(8),2205","journal-title":"Int J Mol Sci"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"3271948","DOI":"10.1155\/2018\/3271948","volume":"2018","author":"Men\u00e9ndez-Men\u00e9ndez J","year":"2018","unstructured":"Men\u00e9ndez-Men\u00e9ndez J; Mart\u00ednez-Campa C.; Melatonin: An anti-tumor agent in hormone-dependent cancers. Int J Endocrinol  2018,2018,3271948","journal-title":"Int J Endocrinol"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"2356","DOI":"10.1002\/jcp.27259","volume":"234","author":"Najafi M.","year":"2019","unstructured":"Najafi M.; Salehi E.; Farhood B.; Nashtaei M.S.; Hashemi Goradel N.; Khanlarkhani N.; Namjoo Z.; Mortezaee K.; Adjuvant chemotherapy with melatonin for targeting human cancers: A review. J Cell Physiol  2019,234(3),2356-2372","journal-title":"J Cell Physiol"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"153226","DOI":"10.1016\/j.prp.2020.153226","volume":"216","author":"Maroufi N.F.","year":"2020","unstructured":"Maroufi N.F.; Ashouri N.; Mortezania Z.; Ashoori Z.; Vahedian V.; Amirzadeh-Iranaq M.T.; Fattahi A.; Kazemzadeh H.; Bizzarri M.; Akbarzadeh M.; Nejabati H.R.; Faridvand Y.; Rashidi M.R.; Nouri M.; The potential therapeutic effects of melatonin on breast cancer: An invasion and metastasis inhibitor. Pathol Res Pract  2020,216(10),153226","journal-title":"Pathol Res Pract"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.biochi.2022.05.012","volume":"202","author":"Sadoughi F.","year":"2022","unstructured":"Sadoughi F.; Maleki Dana P.; Homayoonfal M.; Sharifi M.; Asemi Z.; Molecular basis of melatonin protective effects in metastasis: A novel target of melatonin. Biochimie  2022,202,15-25","journal-title":"Biochimie"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"e24079","DOI":"10.1200\/JCO.2022.40.16_suppl.e24079","volume":"40","author":"Khorasanchi A","year":"2022","unstructured":"Khorasanchi A; Mukhopadhyay N; Pandey S; Nemani S; Parker GL; Urdaneta A; Melatonin supplementation for preventing cancer-related fatigue in patients receiving radiotherapy for early-stage breast cancer: A double-blind placebo-controlled phase III trial. J Clin Oncol  2022,40(16),e24079","journal-title":"J Clin Oncol"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.3390\/cancers11111684","volume":"11","author":"Jung J.H.","year":"2019","unstructured":"Jung J.H.; Shin E.A.; Kim J.H.; Sim D.Y.; Lee H.; Park J.E.; Lee H.J.; Kim S.H.; NEDD9 inhibition by miR-25-5p activation is critically involved in co-treatment of melatonin-and pterostilbene-induced apoptosis in colorectal cancer cells. Cancers  2019,11(11),1684","journal-title":"Cancers"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"1378. e1","DOI":"10.1016\/j.cell.2007.12.011","volume":"131","author":"Semenov MV","year":"2007","unstructured":"Semenov MV; Habas R; MacDonald BT; He X; SnapShot: Noncanonical Wnt signaling pathways. Cell  2007,131(7),1378. e1-1378. e2","journal-title":"Cell"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"6789","DOI":"10.1074\/jbc.M114.612648","volume":"290","author":"Dijksterhuis J.P.","year":"2015","unstructured":"Dijksterhuis J.P.; Baljinnyam B.; Stanger K.; Sercan H.O.; Ji Y.; Andres O.; Rubin J.S.; Hannoush R.N.; Schulte G.; Systematic mapping of WNT-FZD protein interactions reveals functional selectivity by distinct WNT-FZD pairs. J Biol Chem  2015,290(11),6789-6798","journal-title":"J Biol Chem"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"4832","DOI":"10.1096\/fj.201700144R","volume":"31","author":"Voloshanenko O.","year":"2017","unstructured":"Voloshanenko O.; Gmach P.; Winter J.; Kranz D.; Boutros M.; Mapping of Wnt-Frizzled interactions by multiplex CRISPR targeting of receptor gene families. FASEB J  2017,31(11),4832-4844","journal-title":"FASEB J"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1038\/s41380-018-0131-4","volume":"24","author":"Vall\u00e9e A.","year":"2019","unstructured":"Vall\u00e9e A.; Vall\u00e9e J.N.; Lecarpentier Y.; PPAR\u03b3 agonists: Potential treatment for autism spectrum disorder by inhibiting the canonical WNT\/\u03b2-catenin pathway. Mol Psychiatry  2019,24(5),643-652","journal-title":"Mol Psychiatry"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.devcel.2009.06.016","volume":"17","author":"MacDonald B.T.","year":"2009","unstructured":"MacDonald B.T.; Tamai K.; He X.; Wnt\/\u03b2-catenin signaling: Components, mechanisms, and diseases. Dev Cell  2009,17(1),9-26","journal-title":"Dev Cell"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"a007880","DOI":"10.1101\/cshperspect.a007880","volume":"4","author":"MacDonald B.T.","year":"2012","unstructured":"MacDonald B.T.; He X.; Frizzled and LRP5\/6 receptors for Wnt\/\u03b2-catenin signaling. Cold Spring Harb Perspect Biol  2012,4(12),a007880","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/S1534-5807(03)00063-7","volume":"4","author":"Tolwinski N.S.","year":"2003","unstructured":"Tolwinski N.S.; Wehrli M.; Rives A.; Erdeniz N.; DiNardo S.; Wieschaus E.; Wg\/Wnt signal can be transmitted through arrow\/LRP5,6 and Axin independently of Zw3\/Gsk3\u03b2 activity. Dev Cell  2003,4(3),407-418","journal-title":"Dev Cell"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1016\/j.cell.2012.05.002","volume":"149","author":"Li V.S.W.","year":"2012","unstructured":"Li V.S.W.; Ng S.S.; Boersema P.J.; Low T.Y.; Karthaus W.R.; Gerlach J.P.; Mohammed S.; Heck A.J.R.; Maurice M.M.; Mahmoudi T.; Clevers H.; Wnt signaling through inhibition of \u03b2-catenin degradation in an intact Axin1 complex. Cell  2012,149(6),1245-1256","journal-title":"Cell"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1016\/j.cell.2010.11.034","volume":"143","author":"Taelman V.F.","year":"2010","unstructured":"Taelman V.F.; Dobrowolski R.; Plouhinec J.L.; Fuentealba L.C.; Vorwald P.P.; Gumper I.; Sabatini D.D.; De Robertis E.M.; Wnt signaling requires sequestration of glycogen synthase kinase 3 inside multivesicular endosomes. Cell  2010,143(7),1136-1148","journal-title":"Cell"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1242\/jcs.025536","volume":"121","author":"Hendriksen J.","year":"2008","unstructured":"Hendriksen J.; Jansen M.; Brown C.M.; van der Velde H.; van Ham M.; Galjart N.; Offerhaus G.J.; Fagotto F.; Fornerod M.; Plasma membrane recruitment of dephosphorylated \u03b2-catenin upon activation of the Wnt pathway. J Cell Sci  2008,121(11),1793-1802","journal-title":"J Cell Sci"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1038\/nsmb912","volume":"12","author":"Daniels D.L.","year":"2005","unstructured":"Daniels D.L.; Weis W.I.; \u03b2-catenin directly displaces Groucho\/TLE repressors from Tcf\/Lef in Wnt-mediated transcription activation. Nat Struct Mol Biol  2005,12(4),364-371","journal-title":"Nat Struct Mol Biol"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"54","DOI":"10.3390\/cancers8060054","volume":"8","author":"Hao H.X.","year":"2016","unstructured":"Hao H.X.; Jiang X.; Cong F.; Control of Wnt receptor turnover by R-spondin-ZNRF3\/RNF43 signaling module and its dysregulation in cancer. Cancers  2016,8(6),54","journal-title":"Cancers"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1038\/embor.2013.167","volume":"14","author":"Xie Y.","year":"2013","unstructured":"Xie Y.; Zamponi R.; Charlat O.; Ramones M.; Swalley S.; Jiang X.; Rivera D.; Tschantz W.; Lu B.; Quinn L.; Dimitri C.; Parker J.; Jeffery D.; Wilcox S.K.; Watrobka M.; LeMotte P.; Granda B.; Porter J.A.; Myer V.E.; Loew A.; Cong F.; Interaction with both ZNRF3 and LGR4 is required for the signalling activity of R-spondin. EMBO Rep  2013,14(12),1120-1126","journal-title":"EMBO Rep"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1101\/gad.219360.113","volume":"27","author":"Wang D.","year":"2013","unstructured":"Wang D.; Huang B.; Zhang S.; Yu X.; Wu W.; Wang X.; Structural basis for R-spondin recognition by LGR4\/5\/6 receptors. Genes Dev  2013,27(12),1339-1344","journal-title":"Genes Dev"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"eaaz4051","DOI":"10.1126\/scisignal.aaz4051","volume":"13","author":"Park S.","year":"2020","unstructured":"Park S.; Wu L.; Tu J.; Yu W.; Toh Y.; Carmon K.S.; Liu Q.J.; Unlike LGR4, LGR5 potentiates Wnt\u2013\u03b2-catenin signaling without sequestering E3 ligases. Sci Signal  2020,13(660),eaaz4051","journal-title":"Sci Signal"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1038\/ncb2048","volume":"12","author":"Vermeulen L.","year":"2010","unstructured":"Vermeulen L.; De Sousa E Melo F.; van der Heijden M.; Cameron K.; de Jong J.H.; Borovski T.; Tuynman J.B.; Todaro M.; Merz C.; Rodermond H.; Sprick M.R.; Kemper K.; Richel D.J.; Stassi G.; Medema J.P.; Wnt activity defines colon cancer stem cells and is regulated by the microenvironment. Nat Cell Biol  2010,12(5),468-476","journal-title":"Nat Cell Biol"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"5","DOI":"10.4103\/1477-3163.78111","volume":"10","author":"Najdi R.","year":"2011","unstructured":"Najdi R.; Holcombe R.; Waterman M.; Wnt signaling and colon carcinogenesis: Beyond APC. J Carcinog  2011,10(1),5","journal-title":"J Carcinog"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"ra90","DOI":"10.1126\/scisignal.aac6757","volume":"8","author":"Loregger A.","year":"2015","unstructured":"Loregger A.; Grandl M.; Mej\u00edas-Luque R.; Allg\u00e4uer M.; Degenhart K.; Haselmann V.; Oikonomou C.; Hatzis P.; Janssen K.P.; Nitsche U.; Gradl D.; van den Broek O.; Destree O.; Ulm K.; Neumaier M.; Kalali B.; Jung A.; Varela I.; Schmid R.M.; Rad R.; Busch D.H.; Gerhard M.; The E3 ligase RNF43 inhibits Wnt signaling downstream of mutated \u03b2-catenin by sequestering TCF4 to the nuclear membrane. Sci Signal  2015,8(393),ra90","journal-title":"Sci Signal"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1038\/ng.3127","volume":"46","author":"Giannakis M.","year":"2014","unstructured":"Giannakis M.; Hodis E.; Jasmine Mu X.; Yamauchi M.; Rosenbluh J.; Cibulskis K.; Saksena G.; Lawrence M.S.; Qian Z.R.; Nishihara R.; Van Allen E.M.; Hahn W.C.; Gabriel S.B.; Lander E.S.; Getz G.; Ogino S.; Fuchs C.S.; Garraway L.A.; RNF43 is frequently mutated in colorectal and endometrial cancers. Nat Genet  2014,46(12),1264-1266","journal-title":"Nat Genet"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1038\/nature11282","volume":"488","author":"Seshagiri S.","year":"2012","unstructured":"Seshagiri S.; Stawiski E.W.; Durinck S.; Modrusan Z.; Storm E.E.; Conboy C.B.; Chaudhuri S.; Guan Y.; Janakiraman V.; Jaiswal B.S.; Guillory J.; Ha C.; Dijkgraaf G.J.P.; Stinson J.; Gnad F.; Huntley M.A.; Degenhardt J.D.; Haverty P.M.; Bourgon R.; Wang W.; Koeppen H.; Gentleman R.; Starr T.K.; Zhang Z.; Largaespada D.A.; Wu T.D.; de Sauvage F.J.; Recurrent R-spondin fusions in colon cancer. Nature  2012,488(7413),660-664","journal-title":"Nature"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"2911","DOI":"10.2353\/ajpath.2010.091125","volume":"176","author":"Khramtsov A.I.","year":"2010","unstructured":"Khramtsov A.I.; Khramtsova G.F.; Tretiakova M.; Huo D.; Olopade O.I.; Goss K.H.; Wnt\/\u03b2-catenin pathway activation is enriched in basal-like breast cancers and predicts poor outcome. Am J Pathol  2010,176(6),2911-2920","journal-title":"Am J Pathol"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"4474","DOI":"10.1158\/0008-5472.CAN-12-3925","volume":"73","author":"Schade B.","year":"2013","unstructured":"Schade B.; Lesurf R.; Sanguin-Gendreau V.; Bui T.; Deblois G.; O\u2019Toole S.A.; Millar E.K.A.; Zardawi S.J.; Lopez-Knowles E.; Sutherland R.L.; Gigu\u00e8re V.; Kahn M.; Hallett M.; Muller W.J.; \u03b2-Catenin signaling is a critical event in ErbB2-mediated mammary tumor progression. Cancer Res  2013,73(14),4474-4487","journal-title":"Cancer Res"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.bbrc.2010.01.028","volume":"392","author":"Teng Y.","year":"2010","unstructured":"Teng Y.; Wang X.; Wang Y.; Ma D.; Wnt\/\u03b2-catenin signaling regulates cancer stem cells in lung cancer A549 cells. Biochem Biophys Res Commun  2010,392(3),373-379","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1002\/eji.200738118","volume":"38","author":"Staal F.J.","year":"2008","unstructured":"Staal F.J.; Sen J.M.; The canonical Wnt signaling pathway plays an important role in lymphopoiesis and hematopoiesis. Eur J Immunol  2008,38(7),1788-1794","journal-title":"Eur J Immunol"},{"key":"ref=59","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V114.22.2168.2168","author":"Peterson L.F.","year":"2009","unstructured":"Peterson L.F.; Turbiak A.J.; Giannola D.M.; Donato N.; Showalter H.H.; Fearon E.R.; Wnt-pathway directed compound targets blast crisis and chronic phase CML leukemia stem progenitors. Am Soc Hematol  2009","journal-title":"Am Soc Hematol"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"23720","DOI":"10.18632\/oncotarget.4690","volume":"6","author":"Nagaraj A.B.","year":"2015","unstructured":"Nagaraj A.B.; Joseph P.; Kovalenko O.; Singh S.; Armstrong A.; Redline R.; Resnick K.; Zanotti K.; Waggoner S.; DiFeo A.; Critical role of Wnt\/\u03b2-catenin signaling in driving epithelial ovarian cancer platinum resistance. Oncotarget  2015,6(27),23720-23734","journal-title":"Oncotarget"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1111\/j.1365-2559.2012.04355.x","volume":"62","author":"Huss S.","year":"2013","unstructured":"Huss S.; Nehles J.; Binot E.; Wardelmann E.; Mittler J.; Kleine M.A.; K\u00fcnstlinger H.; Hartmann W.; Hohenberger P.; Merkelbach-Bruse S.; Buettner R.; Schildhaus H.U.; \u03b2-Catenin ( CTNNB1 ) mutations and clinicopathological features of mesenteric desmoid-type fibromatosis. Histopathology  2013,62(2),294-304","journal-title":"Histopathology"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1051\/medsci\/20153101015","volume":"31","author":"Mezni I.","year":"2015","unstructured":"Mezni I.; Galichon P.; Bacha M.M.; Sfar I.; Hertig A.; Goucha R.; Xu-Dubois Y.C.; Abderrahim E.; Gorgi Y.; Rondeau E.; Abdallah T.B.; The epithelial-mesenchymal transition and fibrosis of the renal transplant.  Med Sci  2015,31(1),68-74","journal-title":"Med Sci"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"re8","DOI":"10.1126\/scisignal.2005189","volume":"7","author":"Gonzalez D.M.","year":"2014","unstructured":"Gonzalez D.M.; Medici D.; Signaling mechanisms of the epithelial-mesenchymal transition. Sci Signal  2014,7(344),re8","journal-title":"Sci Signal"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"5846","DOI":"10.18632\/oncotarget.3462","volume":"6","author":"Long H.","year":"2015","unstructured":"Long H.; Xiang T.; Qi W.; Huang J.; Chen J.; He L.; Liang Z.; Guo B.; Li Y.; Xie R.; Zhu B.; CD133+ ovarian cancer stem-like cells promote non-stem cancer cell metastasis via CCL5 induced epithelial-mesenchymal transition. Oncotarget  2015,6(8),5846-5859","journal-title":"Oncotarget"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.intimp.2015.02.014","volume":"25","author":"Park J.","year":"2015","unstructured":"Park J.; Yoon J.; Schizandrin inhibits fibrosis and epithelial\u2013mesenchymal transition in transforming growth factor-\u03b21-stimulated AML12 cells. Int Immunopharmacol  2015,25(2),276-284","journal-title":"Int Immunopharmacol"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"13180","DOI":"10.1073\/pnas.0605669103","volume":"103","author":"Kim K.K.","year":"2006","unstructured":"Kim K.K.; Kugler M.C.; Wolters P.J.; Robillard L.; Galvez M.G.; Brumwell A.N.; Sheppard D.; Chapman H.A.; Alveolar epithelial cell mesenchymal transition develops in vivo during pulmonary fibrosis and is regulated by the extracellular matrix. Proc Natl Acad Sci  2006,103(35),13180-13185","journal-title":"Proc Natl Acad Sci"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.1038\/cdd.2010.64","volume":"17","author":"Namba T.","year":"2010","unstructured":"Namba T.; Tanaka K-I.; Ito Y.; Hoshino T.; Matoyama M.; Yamakawa N.; Isohama Y.; Azuma A.; Mizushima T.; Induction of EMT-like phenotypes by an active metabolite of leflunomide and its contribution to pulmonary fibrosis. Cell Death Differ  2010,17(12),1882-1895","journal-title":"Cell Death Differ"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"5567","DOI":"10.3892\/mmr.2016.5950","volume":"14","author":"Yu N.","year":"2016","unstructured":"Yu N.; Sun Y.T.; Su X.M.; He M.; Dai B.; Kang J.; Melatonin attenuates TGF\u03b21-induced epithelial-mesenchymal transition in lung alveolar epithelial cells. Mol Med Rep  2016,14(6),5567-5572","journal-title":"Mol Med Rep"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3322\/caac.21338","volume":"66","author":"Chen W.","year":"2016","unstructured":"Chen W.; Zheng R.; Baade P.D.; Zhang S.; Zeng H.; Bray F.; Jemal A.; Yu X.Q.; He J.; Cancer statistics in China, 2015. CA Cancer J Clin  2016,66(2),115-132","journal-title":"CA Cancer J Clin"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1016\/S0140-6736(15)00055-0","volume":"387","author":"Chua M.L.K.","year":"2016","unstructured":"Chua M.L.K.; Wee J.T.S.; Hui E.P.; Chan A.T.C.; Nasopharyngeal carcinoma. Lancet  2016,387(10022),1012-1024","journal-title":"Lancet"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/j.ijrobp.2010.03.024","volume":"80","author":"Lai S-Z","year":"2011","unstructured":"Lai S-Z; Li W-F; Chen L; Luo W; Chen Y-Y; Liu L-Z; How does intensity-modulated radiotherapy versus conventional two-dimensional radiotherapy influence the treatment results in nasopharyngeal carcinoma patients? Int J Radiat Oncol Biol Phys  2011,80(3),661-668","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1002\/ijc.29486","volume":"137","author":"Chen S.H.","year":"2015","unstructured":"Chen S.H.; Kuo C.C.; Li C.F.; Cheung C.H.A.; Tsou T.C.; Chiang H.C.; Yang Y.N.; Chang S.L.; Lin L.C.; Pan H.Y.; Chang K.Y.; Chang J.Y.;  O -methylguanine DNA methyltransferase repairs platinum-DNA adducts following cisplatin treatment and predicts prognoses of nasopharyngeal carcinoma. Int J Cancer  2015,137(6),1291-1305","journal-title":"Int J Cancer"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.phrs.2016.01.001","volume":"106","author":"Amable L.","year":"2016","unstructured":"Amable L.; Cisplatin resistance and opportunities for precision medicine. Pharmacol Res  2016,106,27-36","journal-title":"Pharmacol Res"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1200\/JCO.2004.06.028","volume":"22","author":"Saurin J.C.","year":"2004","unstructured":"Saurin J.C.; Gutknecht C.; Napoleon B.; Chavaillon A.; Ecochard R.; Scoazec J.Y.; Ponchon T.; Chayvialle J.A.; Surveillance of duodenal adenomas in familial adenomatous polyposis reveals high cumulative risk of advanced disease. J Clin Oncol  2004,22(3),493-498","journal-title":"J Clin Oncol"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.ijrobp.2005.06.037","volume":"64","author":"Baujat B","year":"2006","unstructured":"Baujat B; Audry H; Bourhis J; Chan AT; Onat H; Chua DT; Chemotherapy in locally advanced nasopharyngeal carcinoma: An individual patient data meta-analysis of eight randomized trials and 1753 patients. Int J Radiat Oncol Biol Phys  2006,64(1),47-56","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1136\/tobaccocontrol-2017-053978","volume":"26","author":"Proctor R.N.","year":"2017","unstructured":"Proctor R.N.; FDA\u2019s new plan to reduce the nicotine in cigarettes to sub-addictive levels could be a game-changer. Tob Control  2017,26(5),487-488","journal-title":"Tob Control"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"3256","DOI":"10.1038\/s41467-019-11226-5","volume":"10","author":"Lam W.K.J.","year":"2019","unstructured":"Lam W.K.J.; Jiang P.; Chan K.C.A.; Peng W.; Shang H.; Heung M.M.S.; Cheng S.H.; Zhang H.; Tse O.Y.O.; Raghupathy R.; Ma B.B.Y.; Hui E.P.; Chan A.T.C.; Woo J.K.S.; Chiu R.W.K.; Lo Y.M.D.; Methylation analysis of plasma DNA informs etiologies of Epstein-Barr virus-associated diseases. Nat Commun  2019,10(1),3256","journal-title":"Nat Commun"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"2157","DOI":"10.1158\/1535-7163.MCT-12-1190","volume":"12","author":"Liu R.Y.","year":"2013","unstructured":"Liu R.Y.; Dong Z.; Liu J.; Zhou L.; Huang W.; Khoo S.K.; Zhang Z.; Petillo D.; Teh B.T.; Qian C.N.; Zhang J.T.; Overexpression of asparagine synthetase and matrix metalloproteinase 19 confers cisplatin sensitivity in nasopharyngeal carcinoma cells. Mol Cancer Ther  2013,12(10),2157-2166","journal-title":"Mol Cancer Ther"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"5423","DOI":"10.18632\/aging.102968","volume":"12","author":"Zhang J.","year":"2020","unstructured":"Zhang J.; Xie T.; Zhong X.; Jiang H.L.; Li R.; Wang B.Y.; Huang X.T.; Cen B.H.; Yuan Y.W.; Melatonin reverses nasopharyngeal carcinoma cisplatin chemoresistance by inhibiting the Wnt\/\u03b2-catenin signaling pathway. Aging  2020,12(6),5423-5438","journal-title":"Aging"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/j.euo.2022.10.003","volume":"5","author":"Lobo N.","year":"2022","unstructured":"Lobo N.; Afferi L.; Moschini M.; Mostafid H.; Porten S.; Psutka S.P.; Gupta S.; Smith A.B.; Williams S.B.; Lotan Y.; Epidemiology, screening, and prevention of bladder cancer. Eur Urol Oncol  2022,5(6),628-639","journal-title":"Eur Urol Oncol"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/1756-8722-4-17","volume":"4","author":"Xu X.S.","year":"2011","unstructured":"Xu X.S.; Wang L.; Abrams J.; Wang G.; Histone deacetylases (HDACs) in XPC gene silencing and bladder cancer. J Hematol Oncol  2011,4(1),17","journal-title":"J Hematol Oncol"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"17022","DOI":"10.1038\/nrdp.2017.22","volume":"3","author":"Sanli O.","year":"2017","unstructured":"Sanli O.; Dobruch J.; Knowles M.A.; Burger M.; Alemozaffar M.; Nielsen M.E.; Lotan Y.; Bladder cancer. Nat Rev Dis Primers  2017,3(1),17022","journal-title":"Nat Rev Dis Primers"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.eururo.2017.09.011","volume":"73","author":"Birkenkamp-Demtr\u00f6der K.","year":"2018","unstructured":"Birkenkamp-Demtr\u00f6der K.; Christensen E.; Nordentoft I.; Knudsen M.; Taber A.; H\u00f8yer S.; Lamy P.; Agerb\u00e6k M.; Jensen J.B.; Dyrskj\u00f8t L.; Monitoring treatment response and metastatic relapse in advanced bladder cancer by liquid biopsy analysis. Eur Urol  2018,73(4),535-540","journal-title":"Eur Urol"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"11805","DOI":"10.2147\/OTT.S231489","volume":"12","author":"Cai Z.","year":"2020","unstructured":"Cai Z.; Zhang F.; Chen W.; Zhang J.; Li H.; miRNAs: A promising target in the chemoresistance of bladder cancer. OncoTargets Ther  2020,12,11805-11816","journal-title":"OncoTargets Ther"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"3378","DOI":"10.2174\/138161207782360528","volume":"13","author":"Michaelis M.","year":"2007","unstructured":"Michaelis M.; Doerr H.; Cinatl J.; Valproic acid as anti-cancer drug. Curr Pharm Des  2007,13(33),3378-3393","journal-title":"Curr Pharm Des"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1002\/2211-5463.12223","volume":"7","author":"Liu S.","year":"2017","unstructured":"Liu S.; Liang B.; Jia H.; Jiao Y.; Pang Z.; Huang Y.; Evaluation of cell death pathways initiated by antitumor drugs melatonin and valproic acid in bladder cancer cells. FEBS Open Bio  2017,7(6),798-810","journal-title":"FEBS Open Bio"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"111619","DOI":"10.1016\/j.yexcr.2019.111619","volume":"384","author":"Gu Q.","year":"2019","unstructured":"Gu Q.; Luo Y.; Chen C.; Jiang D.; Huang Q.; Wang X.; GREM1 overexpression inhibits proliferation, migration and angiogenesis of osteosarcoma. Exp Cell Res  2019,384(1),111619","journal-title":"Exp Cell Res"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1002\/ijc.24320","volume":"125","author":"Mirabello L.","year":"2009","unstructured":"Mirabello L.; Troisi R.J.; Savage S.A.; International osteosarcoma incidence patterns in children and adolescents, middle ages and elderly persons. Int J Cancer  2009,125(1),229-234","journal-title":"Int J Cancer"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.gene.2019.01.034","volume":"696","author":"Li L.","year":"2019","unstructured":"Li L.; Wang X.; Liu D.; MicroRNA-185 inhibits proliferation, migration and invasion in human osteosarcoma MG63 cells by targeting vesicle-associated membrane protein 2. Gene  2019,696,80-87","journal-title":"Gene"},{"key":"ref=90","first-page":"6813","volume":"23","author":"Zhang Z.F.","year":"2019","unstructured":"Zhang Z.F.; Xu H.H.; Hu W.H.; Hu T.Y.; Wang X.B.; LINC01116 promotes proliferation, invasion and migration of osteosarcoma cells by silencing p53 and EZH2. Eur Rev Med Pharmacol Sci  2019,23(16),6813-6823","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s12929-017-0353-9","volume":"24","author":"Liu K.","year":"2017","unstructured":"Liu K.; Hou Y.; Liu Y.; Zheng J.; LncRNA SNHG15 contributes to proliferation, invasion and autophagy in osteosarcoma cells by sponging miR-141. J Biomed Sci  2017,24(1),46","journal-title":"J Biomed Sci"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"152534","DOI":"10.1016\/j.prp.2019.152534","volume":"215","author":"Chiappetta C.","year":"2019","unstructured":"Chiappetta C.; Carletti R.; Della Rocca C.; Di Cristofano C.; KMT2C modulates migration and invasion processes in osteosarcoma cell lines. Pathol Res Pract  2019,215(10),152534","journal-title":"Pathol Res Pract"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"108798","DOI":"10.1016\/j.biopha.2019.108798","volume":"114","author":"Wang X.","year":"2019","unstructured":"Wang X.; Hu K.; Chao Y.; Wang L.; LncRNA SNHG16 promotes proliferation, migration and invasion of osteosarcoma cells by targeting miR-1301\/BCL9 axis. Biomed Pharmacother  2019,114,108798","journal-title":"Biomed Pharmacother"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"348","DOI":"10.3390\/cancers11030348","volume":"11","author":"Carina V.","year":"2019","unstructured":"Carina V.; Costa V.; Sartori M.; Bellavia D.; De Luca A.; Raimondi L.; Fini M.; Giavaresi G.; Adjuvant biophysical therapies in osteosarcoma. Cancers  2019,11(3),348","journal-title":"Cancers"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"9543","DOI":"10.1111\/jcmm.16894","volume":"25","author":"Li Y.","year":"2021","unstructured":"Li Y.; Zou J.; Li B.; Du J.; Anticancer effects of melatonin via regulating lncRNA JPX-Wnt\/\u03b2-catenin signalling pathway in human osteosarcoma cells. J Cell Mol Med  2021,25(20),9543-9556","journal-title":"J Cell Mol Med"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.3389\/fimmu.2018.01188","volume":"9","author":"Ou T.","year":"2018","unstructured":"Ou T.; Lilly M.; Jiang W.; The pathologic role of toll-like receptor 4 in prostate cancer. Front Immunol  2018,9,1188","journal-title":"Front Immunol"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1158\/0008-5472.CAN-10-2833","volume":"71","author":"Hsu R.Y.C.","year":"2011","unstructured":"Hsu R.Y.C.; Chan C.H.F.; Spicer J.D.; Rousseau M.C.; Giannias B.; Rousseau S.; Ferri L.E.; LPS-induced TLR4 signaling in human colorectal cancer cells increases \u03b21 integrin-mediated cell adhesion and liver metastasis. Cancer Res  2011,71(5),1989-1998","journal-title":"Cancer Res"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1002\/ar.23590","volume":"300","author":"Li J.","year":"2017","unstructured":"Li J.; Yin J.; Shen W.; Gao R.; Liu Y.; Chen Y.; Li X.; Liu C.; Xiang R.; Luo N.; TLR4 promotes breast cancer metastasis via Akt\/GSK3\u03b2\/\u03b2-catenin pathway upon LPS stimulation. Anat Rec  2017,300(7),1219-1229","journal-title":"Anat Rec"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"1805007","DOI":"10.1002\/adma.201805007","volume":"30","author":"Song W.","year":"2018","unstructured":"Song W.; Tiruthani K.; Wang Y.; Shen L.; Hu M.; Dorosheva O.; Qiu K.; Kinghorn K.A.; Liu R.; Huang L.; Trapping of lipopolysaccharide to promote immunotherapy against colorectal cancer and attenuate liver metastasis. Adv Mater  2018,30(52),1805007","journal-title":"Adv Mater"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1146\/annurev-pathol-020117-043854","volume":"13","author":"Mittal V.","year":"2018","unstructured":"Mittal V.; Epithelial mesenchymal transition in tumor metastasis. Annu Rev Pathol  2018,13(1),395-412","journal-title":"Annu Rev Pathol"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1038\/nrm3758","volume":"15","author":"Lamouille S.","year":"2014","unstructured":"Lamouille S.; Xu J.; Derynck R.; Molecular mechanisms of epithelial\u2013mesenchymal transition. Nat Rev Mol Cell Biol  2014,15(3),178-196","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1038\/nrurol.2017.144","volume":"14","author":"Murillo-Garz\u00f3n V.","year":"2017","unstructured":"Murillo-Garz\u00f3n V.; Kypta R.; WNT signalling in prostate cancer. Nat Rev Urol  2017,14(11),683-696","journal-title":"Nat Rev Urol"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1016\/j.eururo.2014.08.053","volume":"67","author":"Marques R.B.","year":"2015","unstructured":"Marques R.B.; Aghai A.; de Ridder C.M.A.; Stuurman D.; Hoeben S.; Boer A.; Ellston R.P.; Barry S.T.; Davies B.R.; Trapman J.; van Weerden W.M.; High efficacy of combination therapy using PI3K\/AKT inhibitors with androgen deprivation in prostate cancer preclinical models. Eur Urol  2015,67(6),1177-1185","journal-title":"Eur Urol"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1158\/1535-7163.11.3.1","volume":"3","author":"Barton B.E.","year":"2004","unstructured":"Barton B.E.; Karras J.G.; Murphy T.F.; Barton A.; Huang H.F.S.; Signal transducer and activator of transcription 3 (STAT3) activation in prostate cancer: Direct STAT3 inhibition induces apoptosis in prostate cancer lines. Mol Cancer Ther  2004,3(1),11-20","journal-title":"Mol Cancer Ther"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"2253","DOI":"10.2147\/JIR.S305450","volume":"14","author":"Tian Q.X.","year":"2021","unstructured":"Tian Q.X.; Zhang Z.H.; Ye Q.L.; Xu S.; Hong Q.; Xing W.Y.; Chen L.; Yu D.X.; Xu D.X.; Xie D.D.; Melatonin inhibits migration and invasion in LPS-stimulated and-unstimulated prostate cancer cells through blocking multiple EMT-relative pathways. J Inflamm Res  2021,14,2253-2265","journal-title":"J Inflamm Res"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/35102167","volume":"414","author":"Reya T","year":"2001","unstructured":"Reya T; Morrison SJ; Clarke MF; Weissman IL; Stem cells, cancer, and cancer stem cells. Nature  2001,414(6859),105-111","journal-title":"Nature"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"e12808","DOI":"10.1111\/jpi.12808","volume":"73","author":"Sokolov D.","year":"2022","unstructured":"Sokolov D.; Sharda N.; Giri B.; Hassan M.S.; Singh D.; Tarasiewicz A.; Lohr C.; von Holzen U.; Kristian T.; Waddell J.; Reiter R.J.; Ahmed H.; Banerjee A.; Melatonin and andrographolide synergize to inhibit the colospheroid phenotype by targeting Wnt\/beta-catenin signaling. J Pineal Res  2022,73(1),e12808","journal-title":"J Pineal Res"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1200\/JCO.2014.60.1799","volume":"33","author":"Shah M.A.","year":"2015","unstructured":"Shah M.A.; Update on metastatic gastric and esophageal cancers. J Clin Oncol  2015,33(16),1760-1769","journal-title":"J Clin Oncol"},{"key":"ref=109","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/S1055-3207(03)00035-8","volume":"12","author":"Yonemura Y.","year":"2003","unstructured":"Yonemura Y.; Bandou E.; Kinoshita K.; Kawamura T.; Takahashi S.; Endou Y.; Sasaki T.; Effective therapy for peritoneal dissemination in gastric cancer. Surg Oncol Clin N Am  2003,12(3),635-648","journal-title":"Surg Oncol Clin N Am"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1093\/carcin\/bgu232","volume":"36","author":"Kurashige J.","year":"2015","unstructured":"Kurashige J.; Mima K.; Sawada G.; Takahashi Y.; Eguchi H.; Sugimachi K.; Mori M.; Yanagihara K.; Yashiro M.; Hirakawa K.; Baba H.; Mimori K.; Epigenetic modulation and repression of miR-200b by cancer-associated fibroblasts contribute to cancer invasion and peritoneal dissemination in gastric cancer. Carcinogenesis  2015,36(1),133-141","journal-title":"Carcinogenesis"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/j.molonc.2014.12.009","volume":"9","author":"Liu S.H.","year":"2015","unstructured":"Liu S.H.; Lee W.J.; Lai D.W.; Wu S.M.; Liu C.Y.; Tien H.R.; Chiu C.S.; Peng Y.C.; Jan Y.J.; Chao T.H.; Pan H.C.; Sheu M.L.; Honokiol confers immunogenicity by dictating calreticulin exposure, activating ER stress and inhibiting epithelial-to-mesenchymal transition. Mol Oncol  2015,9(4),834-849","journal-title":"Mol Oncol"},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"7788","DOI":"10.18632\/oncotarget.2307","volume":"5","author":"Lai D.W.","year":"2014","unstructured":"Lai D.W.; Liu S.H.; Karlsson A.I.; Lee W.J.; Wang K.B.; Chen Y.C.; Shen C.C.; Wu S.M.; Liu C.Y.; Tien H.R.; Peng Y.C.; Jan Y.J.; Chao T.H.; Lan K.H.; Arbiser J.L.; Sheu M.L.; The novel Aryl hydrocarbon receptor inhibitor biseugenol inhibits gastric tumor growth and peritoneal dissemination. Oncotarget  2014,5(17),7788-7804","journal-title":"Oncotarget"},{"key":"ref=113","doi-asserted-by":"publisher","first-page":"2568","DOI":"10.1093\/carcin\/bgt243","volume":"34","author":"Pan H.C.","year":"2013","unstructured":"Pan H.C.; Lai D.W.; Lan K.H.; Shen C.C.; Wu S.M.; Chiu C.S.; Wang K.B.; Sheu M.L.; Honokiol thwarts gastric tumor growth and peritoneal dissemination by inhibiting Tpl2 in an orthotopic model. Carcinogenesis  2013,34(11),2568-2579","journal-title":"Carcinogenesis"},{"key":"ref=114","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/nrc3205","volume":"12","author":"Gherardi E.","year":"2012","unstructured":"Gherardi E.; Birchmeier W.; Birchmeier C.; Woude G.V.; Targeting MET in cancer: Rationale and progress. Nat Rev Cancer  2012,12(2),89-103","journal-title":"Nat Rev Cancer"},{"key":"ref=115","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/nrc3447","volume":"13","author":"Craene B.D.","year":"2013","unstructured":"Craene B.D.; Berx G.; Regulatory networks defining EMT during cancer initiation and progression. Nat Rev Cancer  2013,13(2),97-110","journal-title":"Nat Rev Cancer"},{"key":"ref=116","doi-asserted-by":"publisher","first-page":"3645","DOI":"10.1158\/0008-5472.CAN-07-2938","volume":"68","author":"Onder T.T.","year":"2008","unstructured":"Onder T.T.; Gupta P.B.; Mani S.A.; Yang J.; Lander E.S.; Weinberg R.A.; Loss of E-cadherin promotes metastasis via multiple downstream transcriptional pathways. Cancer Res  2008,68(10),3645-3654","journal-title":"Cancer Res"},{"key":"ref=117","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1038\/s41586-019-1526-3","volume":"573","author":"Padmanaban V.","year":"2019","unstructured":"Padmanaban V.; Krol I.; Suhail Y.; Szczerba B.M.; Aceto N.; Bader J.S.; Ewald A.J.; E-cadherin is required for metastasis in multiple models of breast cancer. Nature  2019,573(7774),439-444","journal-title":"Nature"},{"key":"ref=118","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.canlet.2016.03.052","volume":"376","author":"Lee C.C.","year":"2016","unstructured":"Lee C.C.; Yang W.H.; Li C.H.; Cheng Y.W.; Tsai C.H.; Kang J.J.; Ligand independent aryl hydrocarbon receptor inhibits lung cancer cell invasion by degradation of Smad4. Cancer Lett  2016,376(2),211-217","journal-title":"Cancer Lett"},{"key":"ref=119","doi-asserted-by":"publisher","first-page":"6829","DOI":"10.3748\/wjg.v22.i30.6829","volume":"22","author":"Kanda M.","year":"2016","unstructured":"Kanda M.; Kodera Y.; Molecular mechanisms of peritoneal dissemination in gastric cancer. World J Gastroenterol  2016,22(30),6829-6840","journal-title":"World J Gastroenterol"},{"key":"ref=120","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1111\/jpi.12295","volume":"60","author":"Wu S.M.","year":"2016","unstructured":"Wu S.M.; Lin W.Y.; Shen C.C.; Pan H.C.; Keh-Bin W.; Chen Y.C.; Jan Y.J.; Lai D.W.; Tang S.C.; Tien H.R.; Chiu C.S.; Tsai T.C.; Lai Y.L.; Sheu M.L.; Melatonin set out to ER stress signaling thwarts epithelial mesenchymal transition and peritoneal dissemination via calpain-mediated C\/EBP \u03b2 and NF \u03ba B cleavage. J Pineal Res  2016,60(2),142-154","journal-title":"J Pineal Res"},{"key":"ref=121","doi-asserted-by":"publisher","first-page":"43","DOI":"10.3322\/canjclin.57.1.43","volume":"57","author":"Jemal A.","year":"2007","unstructured":"Jemal A.; Siegel R.; Ward E.; Murray T.; Xu J.; Thun M.J.; Cancer statistics, 2007. CA Cancer J Clin  2007,57(1),43-66","journal-title":"CA Cancer J Clin"},{"key":"ref=122","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1016\/j.bcp.2008.11.014","volume":"77","author":"Huang C.Y.","year":"2009","unstructured":"Huang C.Y.; Fong Y.C.; Lee C.Y.; Chen M.Y.; Tsai H.C.; Hsu H.C.; Tang C.H.; CCL5 increases lung cancer migration via PI3K, Akt and NF-\u03baB pathways. Biochem Pharmacol  2009,77(5),794-803","journal-title":"Biochem Pharmacol"},{"key":"ref=123","doi-asserted-by":"publisher","first-page":"943","DOI":"10.2147\/CMAR.S187317","volume":"11","author":"Lu T.","year":"2019","unstructured":"Lu T.; Yang X.; Huang Y.; Zhao M.; Li M.; Ma K.; Yin J.; Zhan C.; Wang Q.; Trends in the incidence, treatment, and survival of patients with lung cancer in the last four decades. Cancer Manag Res  2019,11,943-953","journal-title":"Cancer Manag Res"},{"key":"ref=124","doi-asserted-by":"publisher","first-page":"e0200721","DOI":"10.1371\/journal.pone.0200721","volume":"13","author":"Nishio M.","year":"2018","unstructured":"Nishio M.; Sugiyama O.; Yakami M.; Ueno S.; Kubo T.; Kuroda T.; Togashi K.; Computer-aided diagnosis of lung nodule classification between benign nodule, primary lung cancer, and metastatic lung cancer at different image size using deep convolutional neural network with transfer learning. PLoS One  2018,13(7),e0200721","journal-title":"PLoS One"},{"key":"ref=125","doi-asserted-by":"crossref","first-page":"493","DOI":"10.2174\/1574888X12666170523155846","volume":"12","author":"Esendagli D.","year":"2017","unstructured":"Esendagli D.; Gunel-Ozcan A.; From stem cell biology to the treatment of lung diseases. Curr Stem Cell Res Ther  2017,12(6),493-505","journal-title":"Curr Stem Cell Res Ther"},{"key":"ref=126","doi-asserted-by":"publisher","first-page":"16281","DOI":"10.1073\/pnas.0905653106","volume":"106","author":"Bertolini G.","year":"2009","unstructured":"Bertolini G.; Roz L.; Perego P.; Tortoreto M.; Fontanella E.; Gatti L.; Pratesi G.; Fabbri A.; Andriani F.; Tinelli S.; Roz E.; Caserini R.; Lo Vullo S.; Camerini T.; Mariani L.; Delia D.; Calabr\u00f2 E.; Pastorino U.; Sozzi G.; Highly tumorigenic lung cancer CD133  cells display stem-like features and are spared by cisplatin treatment. Proc Natl Acad Sci  2009,106(38),16281-16286","journal-title":"Proc Natl Acad Sci"},{"key":"ref=127","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3390\/cancers8010008","volume":"8","author":"Doherty M.","year":"2016","unstructured":"Doherty M.; Smigiel J.; Junk D.; Jackson M.; Cancer stem cell plasticity drives therapeutic resistance. Cancers  2016,8(1),8","journal-title":"Cancers"},{"key":"ref=128","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1111\/resp.12094","volume":"18","author":"Alamgeer M.","year":"2013","unstructured":"Alamgeer M.; Peacock C.D.; Matsui W.; Ganju V.; Watkins D.N.; Cancer stem cells in lung cancer: Evidence and controversies. Respirology  2013,18(5),757-764","journal-title":"Respirology"},{"key":"ref=129","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1002\/tox.22674","volume":"34","author":"Yang Y.C.","year":"2019","unstructured":"Yang Y.C.; Chiou P.C.; Chen P.C.; Liu P.Y.; Huang W.C.; Chao C.C.; Tang C.H.; Melatonin reduces lung cancer stemness through inhibiting of PLC, ERK, p38, \u03b2-catenin, and Twist pathways. Environ Toxicol  2019,34(2),203-209","journal-title":"Environ Toxicol"},{"key":"ref=130","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1016\/S0140-6736(13)62146-7","volume":"384","author":"Jayson G.C.","year":"2014","unstructured":"Jayson G.C.; Kohn E.C.; Kitchener H.C.; Ledermann J.A.; Ovarian cancer. Lancet  2014,384(9951),1376-1388","journal-title":"Lancet"},{"key":"ref=131","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.ygyno.2015.10.004","volume":"139","author":"Huang T.","year":"2015","unstructured":"Huang T.; Poole E.M.; Okereke O.I.; Kubzansky L.D.; Eliassen A.H.; Sood A.K.; Wang M.; Tworoger S.S.; Depression and risk of epithelial ovarian cancer: Results from two large prospective cohort studies. Gynecol Oncol  2015,139(3),481-486","journal-title":"Gynecol Oncol"},{"key":"ref=132","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1080\/10253890.2016.1203415","volume":"19","author":"Krizanova O.","year":"2016","unstructured":"Krizanova O.; Babula P.; Pacak K.; Stress, catecholaminergic system and cancer. Stress  2016,19(4),419-428","journal-title":"Stress"},{"key":"ref=133","first-page":"4514","volume":"9","author":"Lutgendorf S.K.","year":"2003","unstructured":"Lutgendorf S.K.; Cole S.; Costanzo E.; Bradley S.; Coffin J.; Jabbari S.; Rainwater K.; Ritchie J.M.; Yang M.; Sood A.K.; Stress-related mediators stimulate vascular endothelial growth factor secretion by two ovarian cancer cell lines. Clin Cancer Res  2003,9(12),4514-4521","journal-title":"Clin Cancer Res"},{"key":"ref=134","doi-asserted-by":"publisher","first-page":"3402","DOI":"10.1038\/onc.2014.270","volume":"34","author":"Choi M.J.","year":"2015","unstructured":"Choi M.J.; Cho K.H.; Lee S.; Bae Y.J.; Jeong K.J.; Rha S.Y.; Choi E.J.; Park J.H.; Kim J.M.; Lee J-S.; Mills G.B.; Lee H.Y.; hTERT mediates norepinephrine-induced Slug expression and ovarian cancer aggressiveness. Oncogene  2015,34(26),3402-3412","journal-title":"Oncogene"},{"key":"ref=135","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1158\/1078-0432.CCR-15-1275","volume":"22","author":"Kang Y.","year":"2016","unstructured":"Kang Y.; Nagaraja A.S.; Armaiz-Pena G.N.; Dorniak P.L.; Hu W.; Rupaimoole R.; Liu T.; Gharpure K.M.; Previs R.A.; Hansen J.M.; Rodriguez-Aguayo C.; Ivan C.; Ram P.; Sehgal V.; Lopez-Berestein G.; Lutgendorf S.K.; Cole S.W.; Sood A.K.; Adrenergic stimulation of DUSP1 impairs chemotherapy response in ovarian cancer. Clin Cancer Res  2016,22(7),1713-1724","journal-title":"Clin Cancer Res"},{"key":"ref=136","doi-asserted-by":"publisher","first-page":"S19","DOI":"10.1016\/j.bbi.2012.06.005","volume":"30","author":"Armaiz-Pena G.N.","year":"2013","unstructured":"Armaiz-Pena G.N.; Cole S.W.; Lutgendorf S.K.; Sood A.K.; Neuroendocrine influences on cancer progression. Brain Behav Immun  2013,30(S1),S19-S25","journal-title":"Brain Behav Immun"},{"key":"ref=137","doi-asserted-by":"publisher","first-page":"586757","DOI":"10.3389\/fcell.2020.586757","volume":"8","author":"Jiang S.H.","year":"2020","unstructured":"Jiang S.H.; Zhang X.X.; Hu L.P.; Wang X.; Li Q.; Zhang X.L.; Li J.; Gu J.R.; Zhang Z.G.; Systemic regulation of cancer development by neuro-endocrine-immune signaling network at multiple levels. Front Cell Dev Biol  2020,8,586757","journal-title":"Front Cell Dev Biol"},{"key":"ref=138","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1038\/s41419-020-02906-y","volume":"11","author":"Bu S.","year":"2020","unstructured":"Bu S.; Wang Q.; Sun J.; Li X.; Gu T.; Lai D.; Melatonin suppresses chronic restraint stress-mediated metastasis of epithelial ovarian cancer via NE\/AKT\/\u03b2-catenin\/SLUG axis. Cell Death Dis  2020,11(8),644","journal-title":"Cell Death Dis"}],"container-title":["Current Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0929867330666230409141957","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/215566\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0929867330666230409141957","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,22]],"date-time":"2024-02-22T12:00:36Z","timestamp":1708603236000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/215566\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":138,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0929867330666230409141957","relation":{},"ISSN":["0929-8673"],"issn-type":[{"value":"0929-8673","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2022-11-05","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-02-10","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-02-22","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-01-10","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}